These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 819753)

  • 21. 3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
    Groppetti A; Parenti M; Galli CL; Bugatti A; Cattabeni F; Di Giulio AM; Racagni G
    Life Sci; 1978 Oct; 23(17-18):1763-8. PubMed ID: 31531
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine metabolism in the tuberculum olfactorium.
    Wilk S; Watson E; Glick SD
    Eur J Pharmacol; 1975 Jan; 30(1):117-20. PubMed ID: 1122932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal fluid HVA in the monkey and its pharmacokinetic disposition.
    Elchisak MA; Polinsky RJ; Ebert MH; Powers KJ; Kopin IJ
    Life Sci; 1978 Dec; 23(23):2339-47. PubMed ID: 104110
    [No Abstract]   [Full Text] [Related]  

  • 24. Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
    Extein I; Roth RH; Bowers MB
    Biol Psychiatry; 1974 Oct; 9(2):161-70. PubMed ID: 4429746
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic fate of caudate nucleus dopamine.
    Spano PF; Neff NH
    Brain Res; 1972 Jul; 42(1):139-45. PubMed ID: 5047181
    [No Abstract]   [Full Text] [Related]  

  • 26. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.
    Argiolas A; Paglietti E; Fadda F; Quarantotti BP; Gessa GL
    Life Sci; 1978 Feb; 22(6):461-6. PubMed ID: 625191
    [No Abstract]   [Full Text] [Related]  

  • 28. Catalepsy, DOPAC, and acetylcholine during chronic fluphenazine administration.
    Bowers MB; Bowers SM
    Commun Psychopharmacol; 1978; 2(6):533-7. PubMed ID: 570903
    [No Abstract]   [Full Text] [Related]  

  • 29. The dynamics of dopamine metabolism in various regions of rat brain.
    Karoum F; Neff NH; Wyatt RJ
    Eur J Pharmacol; 1977 Aug; 44(4):311-8. PubMed ID: 891608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
    Tyce GM; Rorie DK
    Life Sci; 1985 Dec; 37(25):2439-48. PubMed ID: 4079658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alpha-methyl fluorodopa on dopamine metabolites: importance of conjugation and egress.
    Sarna GS; Hutson PH; Curzon G
    Eur J Pharmacol; 1984 May; 100(3-4):343-50. PubMed ID: 6203763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid.
    Umezu K; Moore KE
    J Pharmacol Exp Ther; 1979 Jan; 208(1):49-56. PubMed ID: 32385
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in dopamine and DOPAC following systemic administration of apomorphine and 3,4-dihydroxyphenylamino-2-imidazoline (DPI) in rats.
    Springer J; Hannigan JH; Isaacson RL
    Brain Res; 1981 Sep; 220(1):226-30. PubMed ID: 7272755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Serra G; Gessa GL
    Brain Res; 1979 Oct; 175(1):178-82. PubMed ID: 487148
    [No Abstract]   [Full Text] [Related]  

  • 36. Concurrent determination of brain dopamine and 5-hydroxytryptamine turnovers in individual freely moving rats using repeated sampling of cerebrospinal fluid.
    Hutson PH; Sarna GS; Kantamaneni BD; Curzon G
    J Neurochem; 1984 Jul; 43(1):151-9. PubMed ID: 6202842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Gessa GL
    Life Sci; 1979 Jun; 24(24):2279-84. PubMed ID: 502748
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of probenecid on catecholamine metabolites in human cerebrospinal fluid analyzed by mass fragmentography.
    Gordon EK; Oliver J; Kopin IJ
    Life Sci; 1975 May; 16(10):1527-31. PubMed ID: 1195975
    [No Abstract]   [Full Text] [Related]  

  • 39. Levels of HVA and DOPAC in mouse corpus striatum in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    J Neurochem; 1977 Jan; 28(1):227-8. PubMed ID: 833596
    [No Abstract]   [Full Text] [Related]  

  • 40. Acid metabolites of monoamines in avian brain; effects of probenecid and reserpine.
    Ahtee L; Sharman DF; Vogt M
    Br J Pharmacol; 1970 Jan; 38(1):72-85. PubMed ID: 5413292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.